Osteoporotic vertebral compression fractures augmentation by injectable partly resorbable ceramic bone substitute...

Current treatments for osteoporotic vertebral fractures often rely on polymethylmethacrylate, which offers rigidity but lacks resorption properties. Prior research has shown that PMMA can provide structural support but may not adapt to long-term bone healing. No prior work had resolved whether a resorbable alternative could match PMMA’s effectiveness. This gap motivated the exploration of a new injectable ceramic substitute. The need for a material that supports healing while reducing stiffness remains unmet. Existing literature suggests that ceramic composites may offer a safer alternative. However, little is known about their long-term effects on adjacent vertebrae. This study addresses the lack of evidence on resorbable bone substitutes in vertebral augmentation.

The study aimed to assess a new injectable partly resorbable ceramic bone substitute in treating osteoporotic vertebral compression fractures. The specific problem is the lack of alternatives to PMMA that provide both immediate stabilization and long-term healing. The motivation is to reduce complications associated with non-resorbable materials. The goal is to evaluate the material’s effectiveness in pain reduction and functional improvement. The study also examines the impact on adjacent vertebral bodies. The focus is on long-term outcomes over 12 months. The approach is to compare the new material’s performance with established standards. The study’s contribution is to provide evidence for a potentially safer and more adaptable treatment option.

The study involved 80 patients with symptomatic osteoporotic vertebral collapses. Patients were selected based on age and injury criteria. Imaging techniques included CT, X-ray, DEXA, and MRI. Pain levels were measured using the VAS scale. Functional outcomes were assessed with the ODI questionnaire. Procedures were performed under fluoroscopic guidance with a left unilateral approach. Local anesthesia and mild sedation were used. Follow-up assessments occurred at multiple time points. Data collection focused on pain trends and functional recovery.

Pain levels decreased significantly from 7.68 to 0.96 on the VAS at 12 months. The ODI score dropped from 54.78% to 20.12% at six months. No device-related complications were reported. No new adjacent fractures occurred during follow-up. The ceramic substitute showed immediate stabilization effects. Long-term healing was supported by the material’s resorption properties. The material’s lower stiffness compared to PMMA may reduce stress on adjacent vertebrae. The results suggest the ceramic substitute is a viable alternative to PMMA.

The authors propose that the injectable ceramic substitute offers a nontoxic and lower stiffness option compared to PMMA. The material’s resorption properties may support long-term healing. The study suggests the material is effective in pain reduction and functional improvement. No new adjacent fractures were observed, indicating safety. The findings support the material’s use in vertebral augmentation. The results align with the hypothesis that resorbable materials can provide both immediate and long-term benefits. The study does not claim the material is essential but suggests it is a promising alternative. The authors emphasize the need for further research on long-term outcomes.